CIK 0001404281 · Non-accelerated filer<br>Smaller reporting company
Eledon Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 949-238-8090
- Business address
- 19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
- Former names
- Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-09 | BVF PARTNERS L P/IL 10% owner | Purchase | +1,031,385 | 3,361,803 | ||
| 2024-05-09 | BVF PARTNERS L P/IL 10% owner | Purchase | +821,121 | 2,633,679 | ||
| 2024-05-09 | BVF PARTNERS L P/IL 10% owner | Purchase | +75,431 | 220,460 | ||
| 2023-05-05 | BVF PARTNERS L P/IL 10% owner | Purchase | +1,055,445 | 2,330,418 | ||
| 2023-05-05 | BVF PARTNERS L P/IL 10% owner | Purchase | +837,146 | 1,812,558 | ||
| 2023-05-05 | BVF PARTNERS L P/IL 10% owner | Purchase | +86,341 | 145,029 | ||
| 2022-11-23 | Perrin Steven President | Purchase | +1,000 | $2.60 | $3K | 1,000 |
| 2021-12-20 | Gros David-Alexandre C Chief Executive Officer | Purchase | +2,000 | $4.48 | $9K | 9,000 |
| 2021-08-17 | Gros David-Alexandre C Chief Executive Officer | Purchase | +4,000 | $6.21 | $25K | 7,000 |
| 2021-06-11 | Little Paul Sean CHIEF FINANCIAL OFFICER | Purchase | +10,000 | $8.87 | $89K | 10,000 |
| 2021-06-09 | Gros David-Alexandre C Chief Executive Officer | Purchase | +3,000 | $8.01 | $24K | 3,000 |
| 2020-10-30 | Logos Global Management LP 10% owner | Purchase | +5,000 | $24.03 | $120K | 150,000 |
| 2020-10-30 | Logos Global Management LP 10% owner | Purchase | +31,000 | $24.53 | $760K | 181,000 |
| 2020-10-30 | Logos Global Management LP 10% owner | Purchase | +4,000 | $25.97 | $104K | 185,000 |
| 2020-10-30 | Logos Global Management LP 10% owner | Purchase | +15,000 | $26.48 | $397K | 200,000 |
| 2020-10-30 | Logos Global Management LP 10% owner | Purchase | +12,942 | $25.88 | $335K | 200,000 |
| 2020-10-30 | Logos Global Management LP 10% owner | Purchase | +15,000 | $26.17 | $393K | 214,973 |
| 2020-10-30 | Logos Global Management LP 10% owner | Purchase | +9,098 | $25.55 | $232K | 224,071 |
| 2019-05-02 | OrbiMed Israel GP Ltd. Director | Purchase | +646,204 | $3.10 | $2.0M | 3,183,314 |
| 2019-05-02 | Chimovits Erez Director | Purchase | +646,204 | $3.10 | $2.0M | 3,183,314 |
Page 1 of 2 · 32 trades